
World-first clinical trial for sarcoma
Sydney researchers are testing whether an existing medication could be repurposed to treat sarcoma.
Read More


CTC Director to Lead COVID19 Study
CLARITY 2.0 study looks at the Dimerix lead candidate DMX-200 combined with Angiotensin Receptor Blockers to treat respiratory issues associated with COVID19.
Read More